Compare · SKIN vs WST
SKIN vs WST
Side-by-side comparison of SkinHealth Systems Inc. (SKIN) and West Pharmaceutical Services Inc. (WST): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both SKIN and WST operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- WST is the larger of the two at $23.64B, about 287.9x SKIN ($82.1M).
- Over the past year, SKIN is down 60.5% and WST is up 47.1% - WST leads by 107.6 points.
- WST has been more active in the news (5 items in the past 4 weeks vs 2 for SKIN).
- SKIN has more recent analyst coverage (25 ratings vs 17 for WST).
- Company
- SkinHealth Systems Inc.
- West Pharmaceutical Services Inc.
- Price
- $0.63-1.10%
- $334.67+4.58%
- Market cap
- $82.1M
- $23.64B
- 1M return
- +7.80%
- +2.67%
- 1Y return
- -60.50%
- +47.10%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NYSE
- IPO
- 2020
- News (4w)
- 2
- 5
- Recent ratings
- 25
- 17
SkinHealth Systems Inc.
Edge Systems, LLC designs, develops, manufactures, markets, and sells aesthetic technologies and products. It offers hydradermabrasion system that enhances the skin to cleanse, exfoliate, extract, and hydrate simultaneously; Hydraglucan Intense Hydration Booster, a customization for the HydraFacial treatment exfoliates the skin by improving cell renewal and delivers ingredients, including hyaluronic acid, glucan, and betaine to hydrate the skin and provide anti-aging benefits; HydraFacial Daily Essentials, which provides detoxification, rejuvenation, and protection of skin; crystal microdermabrasion systems; and light emitting diode systems. The company also provides HydraFacial CONNECT platform, a three-level industry certification program that will advance aesthetic professionals' skills and give them recognition, respect, and rewards; and system surgical smoke evacuators that vacuums the plume created by laser and electrocautery treatments, such as hair removal, tattoo removal, erbium, and veterinary procedures. Its system surgical smoke evacuators are used by hospitals, plastic surgeons, cosmetic surgeons, OB/GYN, veterinarians, and others. In addition, it offers marketing support services. Its products are distributed worldwide through its sales network. The company was founded in 1997 and is based in Signal Hill, California with a location in Long Beach, California.
West Pharmaceutical Services Inc.
West Pharmaceutical Services, Inc. designs and produces containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.
Latest SKIN
- Hydrafacial Introduces HydraScalp® with Keravive™ as Next Evolution in Scalp Health
- Amendment: SkinHealth Systems Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- SkinHealth Systems Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
- SEC Form 10-Q filed by SkinHealth Systems Inc.
- SkinHealth Systems Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- SkinHealth Systems Reports First Quarter 2026 Financial Results
- SkinHealth Systems Inc. filed SEC Form 8-K: Leadership Update
- Amendment: SEC Form SCHEDULE 13G/A filed by SkinHealth Systems Inc.
- SkinHealth Systems to Report First Quarter 2026 Financial Results on May 7, 2026
- SEC Form DEF 14A filed by SkinHealth Systems Inc.
Latest WST
- West Pharm upgraded by Barclays with a new price target
- Wolfe Research resumed coverage on West Pharm with a new price target
- West Pharmaceutical Services Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- West Appoints Michel Lagarde to be President and Chief Executive Officer
- Amendment: West Pharmaceutical Services Inc. filed SEC Form 8-K: Financial Statements and Exhibits
- SVP, Proprietary Segment Campbell Shane Alden covered exercise/tax liability with 219 shares and converted options into 770 shares, increasing direct ownership by 881% to 613 units (SEC Form 4)
- SEC Form SD filed by West Pharmaceutical Services Inc.
- West Pharmaceutical Services Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Director Pucci Paolo was granted 791 shares, increasing direct ownership by 7% to 11,854 units (SEC Form 4)
- Director Michels Douglas A was granted 791 shares, increasing direct ownership by 2% to 46,496 units (SEC Form 4)